RETN and cryohydrocytosis: For the 513 CHC patients who completed anti-HCV therapy, GEE analysis revealed that the RETN score, SVR, therapeutic intervention, ALT and APRI levels, and WBC count determined the longitudinal trend of the resistin level (Table 3).